The historical rank and industry rank for Collegium Pharmaceutical's Pretax Margin % or its related term are showing as below:
FRA:354'
s Pretax Margin % Range Over the Past 10 Years
Min: -5504.15 Med: -3.72 Max: 15.61
Current: 13.59
FRA:354's Pretax Margin % is ranked better than 66.46% of 954
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs FRA:354: 13.59
Collegium Pharmaceutical (FRA:354) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Collegium Pharmaceutical Pretax Margin % Related Terms
Collegium Pharmaceutical Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:354 vs ALVO, PAHC, BIOA: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Collegium Pharmaceutical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Collegium Pharmaceutical Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Collegium Pharmaceutical's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Collegium Pharmaceutical's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Collegium Pharmaceutical (FRA:354) has a Pretax Margin % of 9.68% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Collegium Pharmaceutical and its competitors. According to the industry distribution chart, Collegium Pharmaceutical ranks #320 out of 954 companies in the Drug Manufacturers industry, placing it in the top 33.5%.
Is Collegium Pharmaceutical's Pretax Margin % too high?
Collegium Pharmaceutical's current Pretax Margin % is 9.68%. The Drug Manufacturers industry median Pretax Margin % is 7.30. Collegium Pharmaceutical's value of 9.68% is 32.7% above this industry median. Based on the distribution chart, Collegium Pharmaceutical ranks #320 out of 954 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Collegium Pharmaceutical has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Collegium Pharmaceutical's Pretax Margin % compare to ALVO and PAHC?
According to the Drug Manufacturers industry distribution chart, Collegium Pharmaceutical ranks #320 out of 954 companies for Pretax Margin %. This puts Collegium Pharmaceutical in the upper half of its industry. The industry median Pretax Margin % is 7.30. Collegium Pharmaceutical's value of 9.68% is 32.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Collegium Pharmaceutical's current Pretax Margin % of 9.68% is 32.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Collegium Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Collegium Pharmaceutical's current Pretax Margin % is 9.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Collegium Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Collegium Pharmaceutical (FRA:354) is currently considered Modestly Undervalued. The stock's GF Value™ is €37.18, compared to a current price of €31.00 — trading 16.6% below its estimated fair value. The current Pretax Margin % is 9.68% and 32.7% above the Drug Manufacturers industry median of 7.30. Collegium Pharmaceutical's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Collegium Pharmaceutical (FRA:354), the current Pretax Margin % is 9.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Collegium Pharmaceutical (FRA:354) Overvalued in 2026?
Based on GuruFocus' analysis, Collegium Pharmaceutical stock appears to be undervalued.
The current stock price of €31.00 is trading 16.6% below its estimated GF Value™ of €37.18.
GuruFocus considers Collegium Pharmaceutical to be Modestly Undervalued.
Key valuation signals for FRA:354:
Pretax Margin %: 9.68%
GF Value™: €37.18 vs. price of €31.00 (16.6% below fair value)
Industry Position: 32.7% above the Drug Manufacturers median (#320 of 954)
No single metric tells the full story. See the FRA:354 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.
75GF Score
Get the complete analysis for FRA:354
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:354 has been successfully added to your 
